FDA Alerts

Osteoporosis
Osteoporosis
04/09/2019
The FDA has approved a new option for the treatment of osteoporosis in postmenopausal women who have a high risk of fracture.
04/09/2019
Osteoporosis
Osteoporosis
01/18/2019
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
01/18/2019
Osteoporosis
Osteoporosis
01/18/2019
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
01/18/2019
Osteoporosis
Osteoporosis
05/22/2018
The US Food and Drug Administration has approved a fifth indication for a human monoclonal antibody commonly used for the treatment of osteoporosis.
05/22/2018
Osteoporosis
Osteoporosis
05/22/2018
The US Food and Drug Administration has approved a fifth indication for a human monoclonal antibody commonly used for the treatment of osteoporosis.
05/22/2018
bone disorders
bone disorders
05/01/2017
The US Food and Drug Administration has approved a new treatment for osteoporosis for postmenopausal women at a high risk for fracture.
05/01/2017